Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07192159 · ClinicalTrials.gov registry record · NA

Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD

A NA study of Metabolic Dysfunction Associated Steatotic Liver Disease and Hepatic Steatosis, sponsored by Seoul National University Hospital.

Recruiting
Registry status
NA
Development phase
62
Enrollment target
2
Study locations

NCT07192159 is a NA study of Metabolic Dysfunction Associated Steatotic Liver Disease and Hepatic Steatosis that is actively recruiting participants, run by Seoul National University Hospital. The registered enrollment target is 62 participants, below the 731-participant average among 7 other Metabolic Dysfunction Associated Steatotic Liver Disease trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07192159, a NA study of Metabolic Dysfunction Associated Steatotic Liver Disease and Hepatic Steatosis, is actively recruiting participants, sponsored by Seoul National University Hospital.

RECRUITING
Registry status
NA
Development phase
62 participants
Enrollment target
2
Study locations

Study Summary

This multicenter prospective study aims to evaluate the correlation between quantitative ultrasound fat fraction (USFF) and MRI-PDFF (Proton Density Fat Fraction) for liver fat quantification in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). The study will compare the diagnostic accuracy of quantitative ultrasound imaging against MRI-PDFF as the reference standard.

Conditions Studied

Metabolic Dysfunction Associated Steatotic Liver Disease Hepatic Steatosis Liver Disease Parenchymal

Interventions

  • DEVICE Quantitative ultrasound (DeepUSFF)

Study Locations (2)

Ohio

  • southwoods imaging (Northeastern Ohio Radiology Research and Education Fund ) - Boardman

Seoul

  • Seoul National University Hospital - Seoul

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2025-06-24
Est. Completion 2026-06-30
Phase NA

Sponsor

Seoul National University Hospital

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07192159

The ClinicalTrials.gov registry entry for NCT07192159 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 731-participant average among 7 other Metabolic Dysfunction Associated Steatotic Liver Disease trials with a reported enrollment target (92% lower). The listed sponsor is Seoul National University Hospital, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Metabolic Dysfunction Associated Steatotic Liver Disease appearing as the primary indexed condition, and to 1 intervention - of which Quantitative ultrasound (DeepUSFF) is the first listed.

NCT07192159 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Seoul.

Frequently Asked Questions

What is clinical trial NCT07192159 about?

NCT07192159 is a clinical study titled "Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD". This multicenter prospective study aims to evaluate the correlation between quantitative ultrasound fat fraction (USFF) and MRI-PDFF (Proton Density Fat Fraction) for liver fat quantification in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). The study will compare th...

What is the current status of trial NCT07192159?

This trial is currently recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2025-06-24. Estimated completion is 2026-06-30.

What conditions does trial NCT07192159 study?

This clinical trial studies the following conditions: Metabolic Dysfunction Associated Steatotic Liver Disease, Hepatic Steatosis, Liver Disease Parenchymal.

What interventions are being tested in trial NCT07192159?

The interventions under investigation include: Quantitative ultrasound (DeepUSFF) (DEVICE).

Who is sponsoring clinical trial NCT07192159?

This trial is sponsored by Seoul National University Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07192159 being conducted?

This trial has 2 study locations across Ohio, Seoul. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Metabolic Dysfunction Associated Steatotic Liver Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Metabolic Dysfunction Associated Steatotic Liver Disease

All registered trials for this condition

Hepatic Steatosis

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.